No abstract available
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Animals
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Apoptosis / drug effects
-
Benzimidazoles / administration & dosage
-
Benzimidazoles / pharmacology
-
Carcinoma, Pancreatic Ductal / drug therapy*
-
Carcinoma, Pancreatic Ductal / metabolism
-
Carcinoma, Pancreatic Ductal / pathology
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Extracellular Signal-Regulated MAP Kinases / metabolism
-
Humans
-
Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
-
Intracellular Signaling Peptides and Proteins / metabolism
-
Mice
-
Mice, Inbred NOD
-
Mice, SCID
-
Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase Kinases / metabolism
-
Models, Biological
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / metabolism
-
Pancreatic Neoplasms / pathology
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / metabolism
-
Ribosomal Protein S6 / antagonists & inhibitors
-
Ribosomal Protein S6 / metabolism
-
Ribosomal Protein S6 Kinases / metabolism
-
Signal Transduction / drug effects*
-
Sirolimus / administration & dosage
-
Sirolimus / pharmacology
-
TOR Serine-Threonine Kinases
-
Xenograft Model Antitumor Assays*
Substances
-
AZD 6244
-
Benzimidazoles
-
Intracellular Signaling Peptides and Proteins
-
Ribosomal Protein S6
-
MTOR protein, human
-
mTOR protein, mouse
-
Protein Serine-Threonine Kinases
-
Ribosomal Protein S6 Kinases
-
TOR Serine-Threonine Kinases
-
Extracellular Signal-Regulated MAP Kinases
-
Mitogen-Activated Protein Kinase Kinases
-
Sirolimus